778 Morbidity and Mortality After Pancreaticoduodenectomy in Patients With Borderline Resectable Type C Clinical Classification

[1]  Brian J. Smith,et al.  A Comprehensive Assessment of Transfusion in Elective Pancreatectomy: Risk Factors and Complications , 2013, Journal of Gastrointestinal Surgery.

[2]  B. Leiby,et al.  Serum Blood Urea Nitrogen and Serum Albumin on the First Postoperative Day Predict Pancreatic Fistula and Major Complications After Pancreaticoduodenectomy , 2013, Journal of Gastrointestinal Surgery.

[3]  M. Braga.  Perioperative immunonutrition and gut function , 2012, Current opinion in clinical nutrition and metabolic care.

[4]  James C. Cox,et al.  Risk factors for 30-day hospital readmission among general surgery patients. , 2012, Journal of the American College of Surgeons.

[5]  S. Candrilli,et al.  Immunonutrition for patients undergoing elective surgery for gastrointestinal cancer: impact on hospital costs , 2012, World Journal of Surgical Oncology.

[6]  C. Scudamore,et al.  Determination of factors predictive of outcome for patients undergoing a pancreaticoduodenectomy of pancreatic head ductal adenocarcinomas. , 2012, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[7]  Justin B Dimick,et al.  Hospital Volume and Failure to Rescue With High-risk Surgery , 2011, Medical care.

[8]  B. Hall,et al.  Postoperative morbidity index: a quantitative measure of severity of postoperative complications. , 2011, Journal of the American College of Surgeons.

[9]  L. Feldman,et al.  Impact of preoperative change in physical function on postoperative recovery: argument supporting prehabilitation for colorectal surgery. , 2011, Surgery.

[10]  J. Birkmeyer,et al.  Trends in hospital volume and operative mortality for high-risk surgery. , 2011, The New England journal of medicine.

[11]  J. Chabot,et al.  Pancreaticoduodenectomy can be Performed Safely in Patients Aged 80 years and Older , 2010, Journal of Gastrointestinal Surgery.

[12]  H. Pitt,et al.  ACS-NSQIP has the potential to create an HPB-NSQIP option. , 2009, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[13]  K. Lillemoe,et al.  Assessment of pancreatic cancer care in the United States based on formally developed quality indicators. , 2009, Journal of the National Cancer Institute.

[14]  T. B. Vaughan,et al.  Intraoperative transfusion of 1 U to 2 U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients. , 2009, Journal of the American College of Surgeons.

[15]  Jeffrey E. Lee,et al.  Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. , 2008, Journal of the American College of Surgeons.

[16]  M. Makary,et al.  Adjuvant chemoradiation therapy after pancreaticoduodenectomy in elderly patients with pancreatic adenocarcinoma. , 2007, International journal of radiation oncology, biology, physics.

[17]  Jeffrey E. Lee,et al.  Delayed recovery after pancreaticoduodenectomy: a major factor impairing the delivery of adjuvant therapy? , 2007, Journal of the American College of Surgeons.

[18]  J. Cameron,et al.  One Thousand Consecutive Pancreaticoduodenectomies , 2006, Annals of surgery.

[19]  L. Way,et al.  Pancreatic resection in the elderly. , 2004, Journal of the American College of Surgeons.

[20]  M. Braga,et al.  Perioperative immunonutrition in patients undergoing cancer surgery: results of a randomized double-blind phase 3 trial. , 1999, Archives of surgery.

[21]  M. Brennan,et al.  Pancreatic or liver resection for malignancy is safe and effective for the elderly. , 1995 .

[22]  T. Kent,et al.  The burden of infection for elective pancreatic resections. , 2013, Surgery.